ICU Pocfratio vs Free Cash Flow Yield Analysis
ICUI Stock | USD 168.46 0.38 0.23% |
ICU Medical financial indicator trend analysis is infinitely more than just investigating ICU Medical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ICU Medical is a good investment. Please check the relationship between ICU Medical Pocfratio and its Free Cash Flow Yield accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICU Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.
Pocfratio vs Free Cash Flow Yield
Pocfratio vs Free Cash Flow Yield Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ICU Medical Pocfratio account and Free Cash Flow Yield. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between ICU Medical's Pocfratio and Free Cash Flow Yield is 0.42. Overlapping area represents the amount of variation of Pocfratio that can explain the historical movement of Free Cash Flow Yield in the same time period over historical financial statements of ICU Medical, assuming nothing else is changed. The correlation between historical values of ICU Medical's Pocfratio and Free Cash Flow Yield is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Pocfratio of ICU Medical are associated (or correlated) with its Free Cash Flow Yield. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow Yield has no effect on the direction of Pocfratio i.e., ICU Medical's Pocfratio and Free Cash Flow Yield go up and down completely randomly.
Correlation Coefficient | 0.42 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Pocfratio
Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Most indicators from ICU Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ICU Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICU Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.As of now, ICU Medical's Selling General Administrative is increasing as compared to previous years. The ICU Medical's current Sales General And Administrative To Revenue is estimated to increase to 0.28, while Tax Provision is forecasted to increase to (46.2 M).
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 491.5M | 697.8M | 739.9M | 776.9M | Total Revenue | 1.3B | 2.3B | 2.3B | 2.4B |
ICU Medical fundamental ratios Correlations
Click cells to compare fundamentals
ICU Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
ICU Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.7B | 1.8B | 1.9B | 4.5B | 4.4B | 4.6B | |
Other Current Liab | 105.8M | 109.0M | 96.5M | 192.9M | 213.7M | 224.4M | |
Total Current Liabilities | 248.5M | 195.5M | 200.8M | 494.6M | 481.8M | 505.9M | |
Total Stockholder Equity | 1.4B | 1.5B | 1.6B | 2.1B | 2.1B | 2.2B | |
Property Plant And Equipment Net | 490.6M | 513.2M | 508.2M | 711.0M | 685.5M | 719.8M | |
Net Debt | (232.4M) | (344.0M) | (507.8M) | 1.4B | 1.5B | 1.5B | |
Retained Earnings | 721.8M | 808.7M | 911.8M | 837.5M | 807.8M | 848.2M | |
Accounts Payable | 128.6M | 71.9M | 81.1M | 215.9M | 150.0M | 157.5M | |
Cash | 268.7M | 396.1M | 552.8M | 208.8M | 254.2M | 137.4M | |
Non Current Assets Total | 810.2M | 842.9M | 850.9M | 3.3B | 3.2B | 3.3B | |
Non Currrent Assets Other | 49.0M | 55.5M | 63.7M | 105.5M | 52.0M | 54.6M | |
Cash And Short Term Investments | 292.6M | 410.8M | 567.2M | 213.0M | 254.7M | 178.0M | |
Net Receivables | 202.2M | 124.1M | 105.9M | 221.7M | 164.3M | 172.5M | |
Common Stock Shares Outstanding | 21.5M | 21.6M | 21.8M | 23.9M | 24.1M | 17.2M | |
Liabilities And Stockholders Equity | 1.7B | 1.8B | 1.9B | 4.5B | 4.4B | 4.6B | |
Inventory | 337.6M | 314.9M | 290.2M | 696.0M | 709.4M | 744.8M | |
Other Stockholder Equity | 668.8M | 693.0M | 721.4M | 1.3B | 1.4B | 1.4B | |
Total Liab | 315.1M | 261.4M | 264.7M | 2.4B | 2.3B | 2.4B | |
Property Plant And Equipment Gross | 490.6M | 513.2M | 468.4M | 711.0M | 1.3B | 1.4B | |
Total Current Assets | 882.2M | 920.8M | 1.0B | 1.2B | 1.2B | 1.3B | |
Accumulated Other Comprehensive Income | (15.4M) | (1.5M) | (19.3M) | (81.0M) | (53.1M) | (50.4M) | |
Non Current Liabilities Total | 66.7M | 65.9M | 63.9M | 1.9B | 1.8B | 1.9B | |
Other Current Assets | 4.4M | 85.5M | 71.3M | 101.6M | 75.0M | 78.8M | |
Intangible Assets | 211.4M | 197.2M | 188.3M | 982.8M | 870.6M | 914.1M | |
Common Stock Total Equity | 2.0M | 2.1M | 2.1M | 2.1M | 2.4M | 1.7M | |
Short Term Investments | 24.0M | 14.7M | 14.4M | 4.2M | 501K | 476.0K | |
Common Stock | 2.1M | 2.1M | 2.1M | 2.4M | 2.4M | 1.8M | |
Other Assets | 77.0M | 146.1M | 106.3M | 104.4M | 120.1M | 126.1M | |
Treasury Stock | (95K) | (157K) | (39K) | (27K) | (31.1K) | (32.6K) | |
Property Plant Equipment | 456.1M | 466.6M | 468.4M | 713.6M | 820.6M | 861.6M | |
Other Liab | 37.8M | 18.1M | 22.1M | 244.7M | 281.4M | 295.5M | |
Net Tangible Assets | 1.2B | 1.3B | 1.6B | (342.1M) | (393.4M) | (373.7M) | |
Current Deferred Revenue | 6.7M | 5.6M | 12.6M | 30.8M | 31.6M | 33.2M | |
Good Will | 31.2M | 33.0M | 43.4M | 1.4B | 1.5B | 1.5B | |
Retained Earnings Total Equity | 620.7M | 721.8M | 808.7M | 911.8M | 1.0B | 553.4M | |
Capital Surpluse | 657.9M | 668.9M | 693.1M | 721.4M | 829.6M | 871.1M | |
Deferred Long Term Liab | 2.1M | 1.7M | 1.5M | 5.2M | 4.6M | 2.7M | |
Long Term Investments | 0.0 | 13.0M | 4.6M | 3.7M | 3.1M | 4.2M | |
Non Current Liabilities Other | 47.3M | 64.3M | 62.4M | 54.4M | 33.9M | 27.4M |
Currently Active Assets on Macroaxis
When determining whether ICU Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ICU Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Icu Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Icu Medical Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICU Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICU Medical. If investors know ICU will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICU Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.24) | Earnings Share (4.56) | Revenue Per Share 96.302 | Quarterly Revenue Growth 0.065 | Return On Assets 0.0066 |
The market value of ICU Medical is measured differently than its book value, which is the value of ICU that is recorded on the company's balance sheet. Investors also form their own opinion of ICU Medical's value that differs from its market value or its book value, called intrinsic value, which is ICU Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICU Medical's market value can be influenced by many factors that don't directly affect ICU Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICU Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICU Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICU Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.